The long mentality on this board is similar to microcap biotech buyout speak
The hubris of hyperbole and self-interest leads to speculation of higher and higher returns when often what is in front of the market as possible, reasonable, and likely, is exactly what is visible: $15/share here.
How many times have retailers in biotech speculated buyout bidding wars only to watch performance and stock price unravel (Dendreon and HGSI as examples, among many). It's the same with these mergers. Often, and necessarily, there is intense regulatory anti-trust scrutiny (although this is a smaller player) that can lead to long slow deterioration of the agreed pps of a merger in the interim. A month from now, this could easily trade down to $13.50+ as retailers see erosion in the interim, become impatient, realize there is no higher upside, all the while suffering OPPORTUNITY COST. In this market, profits will be taken at $15 in order to put that money to work in the market IMMEDIATELY. Anyone who sticks around 6-9 months for this to close risks downside and real opportunity cost.